Review Article

Roles of Dietary Bioactive Peptides in Redox Balance and Metabolic Disorders

Table 3

Molecular mechanisms of action of antidiabetic peptides isolated from various dietary sources.

Dietary protein sourceEnzyme used to produce peptidesPeptide sequence or molecular weightObjectIC50/EC50 valuesActivity/mechanisms of actionReference

Rice branUmamizyme G and bioprase SPDipeptides LP and IPDPP-IV inhibition assayDPP-IV IC50Peptides sowed strong DPP-IV inhibition activity[130]
Egg white albuminAlcalaseKLPGFα-Glucosidase and α-amylase inhibitory assaysα-Glucosidase inhibitory IC50 and α-amylase inhibitory IC50 120 μMKLPGF exhibited strong antidiabetic potential by inhibiting α-glucosidase and α-amylase activities[66]
CaseinProlyl oligopeptidaseFLQPDPP-IV inhibition assayDPP-IV IC50FLQP exhibited DPP-IV inhibition activity[70]
Bovine and porcine meat proteinsPapain and pepsinPPLDPP-IV inhibition assayDPP-IV IC50 390.14 μMPeptides showed DPP-IV inhibition[131]
Porcine skinAlcalase and flavourzymeStreptozotocin-induced diabetic ratsPeptides improved glucose tolerance and inhibited DPP-IV activity and enhanced GLP-1 and the insulin level[132]
Egg yolkProteinase from Asian pumpkinLAPSLPGKPKPDDPP-IV and α-glucosidase assaysDPP-IV IC50 361.5 μmol/L and α-glucosidase IC50 1065.6 μmol/LPeptides showed DPP-IV and α-glucosidase inhibitory activities[67]
Halibut and tilapia skin gelatinFlavourzymeSPGSSGPQGFTG,GPVGPAGNPGANGLN, PPGPTGPRGQPGNIGF, IPGDPGPPGPPGP, LPGERGRPGAPGP, and GPKGDRGLPGPPGRDGMStreptozotocin-induced diabetic ratsPeptides improved glucose tolerance through DPP-IV inhibition and GLP-1 secretion enhancement[73]
Styela clavaProtamexPatients with diabetesPeptides exhibited a decreased hemoglobin A1c and plasma insulin levels[78]
Black beanAlcalaseAKSPLF, LSKSVL, FEELN, and PHLCaco-2 cell and ratsPeptides showed antidiabetic effects by blocking GLUT2 and SGLT1 and reduced glucose absorption and postprandial glucose and blood glucose[133]
WheatBacterial protease770–77740 DaGLUTag cells and ratsPeptides improved hyperglycemia via activating GLP-1 secretion via stimulation of the calmodulin-dependent kinase II pathway mediated by G protein-coupled receptor family C group 6 subtype A[134]
Atlantic cod (Gadus morhua) meatProtamex<2000 Da41 healthy individualsPeptides decreased the postprandial insulin[77]
Oat globulinTrypsinOGb, LQAFEPLR, and EFLLAGNNKCaco-2 cellDPP-IV IC50 OGb 188.1 μg/mL and LQAFEPLR IC50 141.7 μMPeptides showed potent inhibition on DPP4 and α-glucosidase activity and reduced DPP4 protein expression and upregulated the expressions of α-glucosidase, GLUT2, and GLUT5[135]
Milk whey proteinProtease<5000 Da21 prediabetic humansPeptides (1400 or 2800 mg/kg BW) decreased under glucose curve and showed a minor insulinotropic and reduced HbA1c[76]
Egg whiteThermolysin and pepsinIRWTNF-α-treated L6 rat skeletal muscle cellsIRW reduced glucose uptake and enhanced insulin receptor activation and improved insulin sensitivity by inhibiting p38 and JNK1/2 activation[23]
Boarfish (Capros aper) proteinAlcalase and flavourzyme<2 kDaBRIN-BD11 and GLUTag cells and miceDPP-IV inhibitory activity IC50 1.18 mg/mLPeptides increased insulin secretion and inhibited DPP-IV activity. Peptides increased insulin levels and reduced glucose concentration[72]
Blue whiting (Micromesistius poutassou) muscle proteinAlcalase and flavourzyme<5 kDaGLUTag cells, BRIN-BD11 cells, 3T3-L1 adipocytes, DPP-IV assay, and miceDPP-IV inhibitory activity IC50Peptides showed being antidiabetic via DPP-IV inhibitory activity, increasing insulin-stimulated glucose, stimulating insulin secretion and GLP-1, and decreasing glucose[71]
Potato proteinAlcalaseDIKTNKPVIFDiabetic micePeptides showed antidiabetic effects via regulation of blood glucose, plasma total glycerol, total cholesterol, insulin, and HbA1c[6]
Spirulina platensisGVPMPNK, RNPFVFAPTLLTVAAR, and LRSELAAWSRα-Amylase, α-glucosidase, and DPP-IV assayα-Amylase IC50 313.6 μg/mL, α-glucosidase IC50 134.2 μg/mL, and DPP-IV IC50 167.3 μg/mLLRSELAAWSR exhibited strong inhibitory activity on α-amylase, α-glucosidase, and DPP-IV[68]
Beans (Phaseolus vulgaris L.)Pepsin and pancreatin<3 kDaWistar rats and mice and in vitro assaysα-Amylase 16.9–89.1% and α-glucosidase inhibition 34.4–89.2%Fractions inhibited α-amylase and α-glucosidase. Fractions showed both hypoglycemic and antihyperglycemic activities[136]
Soy proteinPapain, trypsin, and alkaline proteinaseLLPLPVL, SWLRL, and WLRLα-Glucosidase inhibitory assayα-Glucosidase IC50 162.2–237.4 μmol/LPeptides showed strong α-glucosidase inhibitory activity[63]
Sea cucumber (Holothuria nobilis)Mixture of papain and protamex203–1907 DaType II diabetic rats induced by streptozotocinPeptides (200 and 400 mg/kg BW) decreased fasting blood glucose. Peptides showed antidiabetic effects by increasing the expressions of PI3K, p-Akt, p-GSK-3β, and GLUT2/4 signaling pathways and decreasing the expression of p-IRS1[73]
Largemouth bass (Micropterus salmoides)Pepsin, trypsin, and chymotrypsinICYDPP-IV inhibitory assayDPP-IV IC50 0.73 mMICY had strong DPP4 inhibitory activities[137]
Zebra blenny (Salaria basilisca) proteinCrude alkaline protease extract from zebra blenny>30 kDaDPP-IV inhibitory assayDPP-IV IC50 71 μg/mLFraction showed α-amylase inhibitory activity[64]
Walnut (Juglans mandshurica Maxim)AlcalaseLPLLRHepatic HepG2 cells and in vitro assaysInhibiting α-glucosidase 50.12% and α-amylase 39.08% at 2000 μMLPLLR inhibited α-glucosidase and α-amylase and improved hepatic insulin resistance via enhancing glycogen synthesis and glucose uptake and reduced gluconeogenesis via activating the IRS-1/PI3K/Akt and AMPK pathways[75]
Quinoa proteinBromelain, chymotrypsin, and Pronase EQHPHGLGALCAAPPSTα-Glucosidase and DPP-IV inhibitory assaysDPP-IV IC50 0.72–1.12 mg/mL and α-glucosidase IC50 1.0–1.45 mg/mLPeptides showed antidiabetic effects by inhibiting DPP-IV and α-glucosidase[62]
Corn germ proteinAlcalase, trypsin, and flavourzyme<2–10 kDaIn vitro assaysInhibiting α-amylase 71.3%, α-glucosidase 37.1%, and DPP-IV 45.9%Peptides showed strong α-amylase, α-glucosidase, and DPP-IV inhibition[61]
Sea cucumber (Stichopus japonicus)Pepsin, trypsin, and chymotrypsin<3 kDa3T3-L1 and Hep G2 cellsDPP-IV IC50 0.51–0.52 mg/mLPeptides improved glucose uptake and DPP-IV inhibitory activity[7]
α-Lactalbumin-rich whey proteinsTrypsinLDQWLCEKLDPP-IV inhibitory activityDPP-IV inhibition IC50 131 μMLDQWLCEKL exhibited DPP-IV inhibition with a noncompetition[138]
Palmaria palmataAlcalase and flavourzyme<1–5 kDaStreptozotocin-induced diabetic micePeptides showed antidiabetic effects by reducing blood glucose and increasing insulin and improved terminal oral glucose tolerance and fasting blood glucose[139]
Atlantic salmon (Salmo salar) skinTrypsinLDKVFRDPP-IV inhibitory activity assayDPP-IV inhibition IC50 128.7 μMLDKVFR showed DPP-IV inhibition[14]
Millet proteinsPapainNDWHTGPLS and TYPHQQPPILTDPP-IV inhibition assayDPP-IV inhibition 75.72%Peptides inhibited DPP-IV and occupied DPP-IV active center (S1 and S2 subsites) via H-bond and [21]

Akt: protein kinase B; AMPK: AMP-activated protein kinase; DPP-IV: dipeptidyl peptidase-IV; GLP-1: glucagon-like peptide-1; GLUT: glucose transporter; HbA1c: glycosylated hemoglobin; IC50: 50% inhibitory concentration; STZ: streptozotocin; PI3K: phosphatidylinositol 3-kinase; p-Akt: phosphorylated protein kinase B; p-IRS1: phosphorylated insulin receptor substrate-1; IRS-1: insulin receptor substrate-1; JNK: c-Jun N-terminal kinase.